In SLE, the expression of BTLA on naive B cells is inversely associated with SIGLEC-1 expression on monocytes, a type I IFN marker that contributes to the IFN signature which is related to disease activity in SLE, and autoantibody titers [24]. Here, SIGLEC1 is linked to systemic lupus erythematosus.